These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3107190)

  • 1. [Pulmonary fibrosis following instillation of mitomycin C in the urinary bladder].
    Neubauer H; Blech M; Wilhelms E; Crieé CP; Neuhaus KL; Truss F
    Urologe A; 1987 Jan; 26(1):41-3. PubMed ID: 3107190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lung sarcoidosis following instillation of mitomycin C in the urinary bladder].
    Cuervo Pinna MA; Cuervo Pinna C; Macías Castillo S; Bureo Dacal JC; Espada Alonso MJ; Pimentel Leo J
    An Med Interna; 2001 Dec; 18(12):641-3. PubMed ID: 11852501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical mitomycin C for superficial transitional cell carcinoma.
    Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
    van der Meijden AP; DeBruyne FM
    Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lung parenchyma disease following instillation of mitomycin C in the bladder].
    Wilhelms E; Criée CP; Neubauer H; Neuhaus KL
    Dtsch Med Wochenschr; 1986 Oct; 111(41):1564-6. PubMed ID: 3095083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports].
    Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ
    Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH; Bouffioux C; Sylvester R; de Pauw M
    Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
    [No Abstract]   [Full Text] [Related]  

  • 8. Bladder wall fibrosis following intravesical mitomycin treatment for superficial bladder cancer.
    Katz G; Hackett RL; Wajsman Z
    Urology; 1996 Jun; 47(6):928-9. PubMed ID: 8677595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of mitomycin C perfusion after bladder tumor surgery].
    Zhou CL
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):654-5, 700. PubMed ID: 2517250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels during intravesical instillation of mitomycin-C.
    Kurth KH; de Wall JG; van Oosterom AT; de Jong EA; Tjaden UR
    Prog Clin Biol Res; 1985; 185B():81-93. PubMed ID: 3929272
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report.
    DeFuria MD; Bracken RB; Johnson DE; Soloway MS; Merrin CE; Morgan LR; Miller HC; Crooke ST
    Cancer Treat Rep; 1980; 64(2-3):225-30. PubMed ID: 7407754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcified bladder lesions secondary to the instillation of mitomycin C].
    Megias Garrigós J; Pelluch Auladell A; Romero Pérez P; Fernandez García J; Gassó Matoses M; Sánchez Marcos M; Mira Llinarés A
    Arch Esp Urol; 1991 Nov; 44(9):1057-60. PubMed ID: 1807206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical chemotherapy: how effective is it?
    Heney NM
    Urology; 1988 Mar; 31(3 Suppl):17-9. PubMed ID: 3126591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical studies on intravesical instillation therapy for bladder cancer].
    Yamanaka H; Kaburagi Y; Imai K; Miki M
    Hinyokika Kiyo; 1983 Nov; 29(11):1427-32. PubMed ID: 6428193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction and overview of intravesical therapy for superficial bladder cancer.
    Soloway MS
    Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incrusted cystitis after intravesical mitomycin C treatment.
    Llopis M; Moreno J; Botella R; Algado M
    Acta Urol Belg; 1993 Sep; 61(3):21-3. PubMed ID: 8256682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer.
    Baker WC; Russo MA; deVere White RW
    Urology; 1987 Oct; 30(4):357-8. PubMed ID: 3116739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
    Drago PC; Badalament RA; Lucas J; Drago JR
    J Urol; 1989 Oct; 142(4):1071-2. PubMed ID: 2507794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal failure after intravesical mitomycin C.
    Farha AJ; Krauss DJ
    Urology; 1989 Oct; 34(4):216-7. PubMed ID: 2508290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.